Top Industry Players in Thailand Eczema Market | Competitive Landscape 2026

Thailand Eczema Market Overview

According to 6Wresearch, the Thailand eczema market is witnessing significant expansion due to rising urban pollution levels, increased clinical awareness of Atopic Dermatitis, and a growing geriatric population. The market is characterized by a high demand for non-steroidal alternatives and barrier-repair emollients.

Furthermore, the Thai government's "Health for All" initiative has improved access to specialized dermatological care in public hospitals, while the private aesthetic and wellness sectors continue to dominate the premium derma-cosmetic market via dermatological clinics and retail pharmacy chains.

Competitive Landscape

The competitive landscape of the Thailand eczema market is characterized by intense R&D competition between global biopharmaceutical firms and local generic producers. Strategic marketing focuses on "steroid-free" labeling and pediatric-safe formulations to cater to the significant demand for childhood eczema treatments.

Below is a list of leading players operating in the Thailand Eczema Market:

1. Sanofi S.A.

A market leader in the severe eczema segment with its biological blockbuster Dupixent, which has revolutionized the treatment of moderate-to-severe atopic dermatitis in Thailand.

2. LEO Pharma A/S

A dedicated dermatology specialist providing a wide range of topical treatments and systemic options, focusing on chronic inflammatory skin conditions.

3. Biolab Co., Ltd.

A major domestic manufacturer and CDMO under the Biopharm Group, specializing in high-quality dermatological formulations and barrier-repair creams.

4. Bangkok Lab and Cosmetic PCL (BLC)

A leading domestic player that focuses on derma-cosmetics and topical medicines, providing affordable eczema management solutions under PIC/S GMP standards.

5. Pfizer Inc.

Active in the Thai market with its innovative JAK inhibitor Cibinqo, targeting patients who require systemic relief from chronic itch and inflammation.

6. Galderma S.A.

The manufacturer of Cetaphil, a brand that holds a dominant position in Thailand's supportive care market for eczema-prone skin.

7. Bayer AG

Markets the widely recognized Bepanthen range, which is a household name in Thailand for baby eczema and sensitive skin barrier repair.

8. Siam Pharmaceutical Co., Ltd.

A local giant providing a diverse portfolio of cost-effective generic topical steroids and anti-inflammatory medications.

9. La Roche-Posay

A key player in the active cosmetics segment with its Lipikar line, frequently recommended by Thai dermatologists for eczema maintenance.

10. GlaxoSmithKline (GSK) PLC

Distributes the Physiogel and Oilatum brands in Thailand, focusing on restoring the lipid barrier in patients with dry, eczema-prone skin.

11. Thai Nakorn Patana Co., Ltd.

A retail-focused manufacturer that ensures broad availability of basic topical anti-itch treatments across Thailand's extensive pharmacy network.

12. Abbott Laboratories

Supplies various dermatological products and nutritional supplements that support overall skin health and immune function in eczema patients.

13. Vesco Pharmaceutical Co., Ltd.

Specializes in manufacturing essential generic ointments and dermatological solutions for both the domestic Thai and regional ASEAN markets.